Brown Brothers Harriman & CO Surface Oncology, Inc. Transaction History

Brown Brothers Harriman & CO

  • $14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.16 - $7.98 $10,320 - $15,960
-2,000 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$6.45 - $9.09 $12,900 - $18,180
2,000 New
2,000 $15,000
Q1 2020

May 15, 2020
SELL
$1.44 - $3.95 $2,646 - $7,260
-1,838 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$3.65 - $10.69 $6,708 - $19,648
1,838 New
1,838 $8,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email